Showing results (21-30 of 229) with videos related to
Sort By:
Pageof 23
British Journal of Cancer|June 1, 1995
Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative GroupR de Wit, G Stoter, D T Sleijfer, et al.Journal of the National Cancer Institute|May 26, 1999
Impact of the treating institution on survival of patients with "poor-prognosis" metastatic nonseminoma. European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Collaborative Group and the Medical Research Council Testicular Cancer Working PartyL Collette, R J Sylvester, S P Stenning, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2000
A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remissionS Rodenhuis, R de Wit, P H de Mulder, et al.Pharmaceutisch Weekblad. Scientific Edition|February 22, 1991
Pathophysiology of cytotoxic drug-induced emesis: far from crystal-clearC Seynaeve, P H De Mulder, J VerweijNederlands Tijdschrift Voor Geneeskunde|February 24, 1999
[Immunology in clinical practice. XVII. Immunotherapy of metastatic renal cell carcinoma. Work Group Immunotherapy, Dutch Oncology]C M van Herpen, P H de MulderAnnals of Oncology : Official Journal of the European Society for Medical Oncology|December 6, 2000
Locoregional immunotherapy in cancer patients: review of clinical studiesC M van Herpen, P H De MulderAnti-Cancer Drugs|August 1, 1991
5-HT3 receptor antagonists, a new approach in emesis: a review of ondansetron, granisetron and tropisetronC Seynaeve, J Verweij, P H de MulderBritish Journal of Cancer|November 21, 1998
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceR de Wit, L Collette, R Sylvester, et al.Nederlands Tijdschrift Voor Geneeskunde|November 16, 2005
[Effective chemotherapy for hormone-refractory prostate cancer: docetaxel-prednisone]E Batman, R de WitNederlands Tijdschrift Voor Geneeskunde|July 13, 2001
[Treatment of metastatic testicular carcinoma according to prognosis; new development]R de Wit, G StoterPageof 23